If you’re following debates in the Senate, you may have heard Sen. Elizabeth Warren (D-MA) and others refer to one important piece of pending legislation, the 21st Century Cures Act, as “corrupt” and “dangerous.”
Well, she certainly got my attention. But what is really alarming is that Sen. Warren’s attack is baseless. In fact, the effort to derail the 21st Century Cures Act is what is really dangerous—and alarming.
Manufacturers of medical devices and pharmaceuticals save lives and improve the human condition. Their breakthroughs in scientific advances and technological innovations create jobs for scientists and researchers as well as machinists and those on the manufacturing line.
Their work is essential to both the health of our families and our economy.
Unfortunately, due to an outdated federal device and drug approval process, manufacturers in the United States face burdensome costs and unnecessary delays in the development of innovative, lifesaving products.
The 21st Century Cures legislation works to address these challenges. It will modernize our approach to the discovery, development and delivery of medical innovations to ensure that the United States maintains its rightful position of leadership in the global economy at a time when foreign competitors are catching up.
This bill, which represents a bipartisan negotiation in the House and Senate, has been significantly debated over the past two years. The act focuses on important investments in basic research that will lead to further advancement in the development of treatments and products, help fight diseases and other chronic conditions and allow for small business flexibility to provide health care options to employees.
In addition, the legislation also includes a fix to the Affordable Care Act that will allow small businesses to use Health Reimbursement Arrangements to provide health care options for their employees, a practice that is currently heavily fined by the IRS.
Attempts to call this effort “corrupt” and “dangerous” are baseless and more about making points based on political rhetoric, completely ignoring the positive and much needed provisions of the legislation.
Too much progress is at stake. Americans should hold Sen. Warren accountable for attempting to hold up these much needed medical advances—all to score political points.
Latest posts by Jay Timmons (see all)
- NAFTA: A Win for Manufacturing Workers - August 16, 2017
- Why Manufacturers Are Cheering Energy Week - June 29, 2017
- Manufacturers on the President’s Cuba Announcement - June 16, 2017